JP2022525099A5 - - Google Patents
Info
- Publication number
- JP2022525099A5 JP2022525099A5 JP2021554674A JP2021554674A JP2022525099A5 JP 2022525099 A5 JP2022525099 A5 JP 2022525099A5 JP 2021554674 A JP2021554674 A JP 2021554674A JP 2021554674 A JP2021554674 A JP 2021554674A JP 2022525099 A5 JP2022525099 A5 JP 2022525099A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- polynucleotide
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816746P | 2019-03-11 | 2019-03-11 | |
| US62/816,746 | 2019-03-11 | ||
| PCT/US2020/021916 WO2020185796A1 (en) | 2019-03-11 | 2020-03-10 | High avidity wt1 t cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525099A JP2022525099A (ja) | 2022-05-11 |
| JP2022525099A5 true JP2022525099A5 (https=) | 2023-03-17 |
| JP7611844B2 JP7611844B2 (ja) | 2025-01-10 |
Family
ID=70155376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554674A Active JP7611844B2 (ja) | 2019-03-11 | 2020-03-10 | 高アビディティｗｔ１ｔ細胞受容体とその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12448430B2 (https=) |
| EP (1) | EP3938386A1 (https=) |
| JP (1) | JP7611844B2 (https=) |
| KR (1) | KR20210138043A (https=) |
| CN (1) | CN113784978B (https=) |
| AU (1) | AU2020237043A1 (https=) |
| BR (1) | BR112021017703A8 (https=) |
| CA (1) | CA3132845A1 (https=) |
| EA (1) | EA202192252A1 (https=) |
| IL (1) | IL286202A (https=) |
| MX (1) | MX2021010837A (https=) |
| SG (1) | SG11202109745PA (https=) |
| WO (1) | WO2020185796A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240007775A (ko) | 2016-12-08 | 2024-01-16 | 이매틱스 바이오테크놀로지스 게엠베하 | T 세포 수용체 및 이를 사용하는 면역 요법 |
| TW202241938A (zh) * | 2020-12-31 | 2022-11-01 | 美商英麥提克斯股份有限公司 | Ｃｄ８多肽、組合物及其使用方法 |
| JP2025535502A (ja) * | 2022-10-28 | 2025-10-24 | バイオサイトジェン ファーマシューティカルズ （ベイジン） カンパニー リミテッド | 抗ｗｔ１／ｈｌａ抗体及びその使用 |
| WO2025029648A1 (en) * | 2023-07-28 | 2025-02-06 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting loxhd1-associated disease |
| WO2025245169A1 (en) | 2024-05-21 | 2025-11-27 | Fred Hutchinson Cancer Center | Immunotherapy cells equipped with a collagen-targeting payload |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
| AU2003215869B2 (en) | 2002-03-15 | 2008-04-24 | Cellectis | Hybrid and single chain meganucleases and use thereof |
| WO2004024175A1 (ja) | 2002-09-12 | 2004-03-25 | Haruo Sugiyama | 癌抗原ペプチド製剤 |
| EP3202899B1 (en) | 2003-01-28 | 2020-10-21 | Cellectis | Custom-made meganuclease and use thereof |
| GB0328363D0 (en) | 2003-12-06 | 2004-01-14 | Imp College Innovations Ltd | Therapeutically useful molecules |
| PT1731605E (pt) | 2004-03-31 | 2010-04-14 | Int Inst Cancer Immunology Inc | Péptidos antigénicos de cancro derivados de wt1 |
| JP2008527001A (ja) | 2005-01-13 | 2008-07-24 | ザ ジョンズ ホプキンス ユニバーシティー | 前立腺幹細胞抗原ワクチンおよびその使用 |
| ES2582091T3 (es) | 2005-10-18 | 2016-09-09 | Precision Biosciences | Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas |
| US8119772B2 (en) | 2006-09-29 | 2012-02-21 | California Institute Of Technology | MART-1 T cell receptors |
| EP2210903A1 (en) | 2009-01-21 | 2010-07-28 | Monoclonal Antibodies Therapeutics | Anti-CD160 monoclonal antibodies and uses thereof |
| EP2258719A1 (en) | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| US8586526B2 (en) | 2010-05-17 | 2013-11-19 | Sangamo Biosciences, Inc. | DNA-binding proteins and uses thereof |
| US9676854B2 (en) | 2011-08-15 | 2017-06-13 | Medimmune, Llc | Anti-B7-H4 antibodies and their uses |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US20140186843A1 (en) | 2012-12-12 | 2014-07-03 | Massachusetts Institute Of Technology | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| CA2894879A1 (en) | 2012-12-19 | 2014-06-26 | Amplimmune, Inc. | B7-h4 specific antibodies, and compositions and methods of use thereof |
| CA2930877A1 (en) | 2013-11-18 | 2015-05-21 | Crispr Therapeutics Ag | Crispr-cas system materials and methods |
| KR102415259B1 (ko) | 2013-11-22 | 2022-06-30 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 조작된 고-친화도의 인간 t 세포 수용체 |
| ES2841274T3 (es) | 2014-08-04 | 2021-07-07 | Hutchinson Fred Cancer Res | Inmunoterapia con células T específica para WT-1 |
| WO2016040724A1 (en) | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anti-b7-h4 antibodies and immunoconjugates |
| RU2017115315A (ru) | 2014-10-03 | 2018-11-08 | Дана-Фарбер Кэнсер Инститьют, Инк. | Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения |
| DK3653221T5 (da) | 2015-02-19 | 2024-08-26 | Compugen Ltd | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder |
| EP4406604A3 (en) | 2015-03-05 | 2024-10-23 | Fred Hutchinson Cancer Center | Immunomodulatory fusion proteins and uses thereof |
| JO3620B1 (ar) | 2015-08-05 | 2020-08-27 | Amgen Res Munich Gmbh | مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم |
| US11047011B2 (en) | 2015-09-29 | 2021-06-29 | iRepertoire, Inc. | Immunorepertoire normality assessment method and its use |
| WO2017112944A1 (en) | 2015-12-23 | 2017-06-29 | Fred Hutchinson Cancer Research Center | High affinity t cell receptors and uses thereof |
| JP2019515656A (ja) | 2016-03-15 | 2019-06-13 | キャンサー・リサーチ・テクノロジー・リミテッドＣａｎｃｅｒ Ｒｅｓｅａｒｃｈ Ｔｅｃｈｎｏｌｏｇｙ Ｌｉｍｉｔｅｄ | キメラ抗原受容体 |
| CN109996868A (zh) | 2016-09-23 | 2019-07-09 | 弗雷德哈钦森癌症研究中心 | 特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途 |
| JP7328211B2 (ja) | 2017-04-24 | 2023-08-16 | オスペダーレ サン ラファエレ エス．アール．エル | Ｔｃｒ及びペプチド |
| WO2019178427A1 (en) | 2018-03-14 | 2019-09-19 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
-
2020
- 2020-03-10 WO PCT/US2020/021916 patent/WO2020185796A1/en not_active Ceased
- 2020-03-10 JP JP2021554674A patent/JP7611844B2/ja active Active
- 2020-03-10 US US17/438,380 patent/US12448430B2/en active Active
- 2020-03-10 EA EA202192252A patent/EA202192252A1/ru unknown
- 2020-03-10 BR BR112021017703A patent/BR112021017703A8/pt unknown
- 2020-03-10 CN CN202080033281.4A patent/CN113784978B/zh active Active
- 2020-03-10 CA CA3132845A patent/CA3132845A1/en active Pending
- 2020-03-10 SG SG11202109745P patent/SG11202109745PA/en unknown
- 2020-03-10 MX MX2021010837A patent/MX2021010837A/es unknown
- 2020-03-10 EP EP20716656.2A patent/EP3938386A1/en active Pending
- 2020-03-10 KR KR1020217032466A patent/KR20210138043A/ko not_active Ceased
- 2020-03-10 AU AU2020237043A patent/AU2020237043A1/en not_active Abandoned
-
2021
- 2021-09-09 IL IL286202A patent/IL286202A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525099A5 (https=) | ||
| JP2024074801A5 (https=) | ||
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| JP2017523784A5 (https=) | ||
| Criscitiello | Tumor-associated antigens in breast cancer | |
| JP7577252B2 (ja) | ＣＤ３００ｃの発現抑制剤または活性抑制剤を含む癌の予防または治療用薬学的組成物 | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| JP2021512637A5 (https=) | ||
| Zhang et al. | Genetic engineering with T cell receptors | |
| Franks et al. | New anticancer immunotherapies | |
| JP2022553292A5 (https=) | ||
| JP2021525068A5 (https=) | ||
| CN114555815B (zh) | T细胞受体及其使用方法 | |
| JP2022506781A5 (https=) | ||
| JP2022547809A5 (https=) | ||
| JP2024528029A5 (https=) | ||
| TWI785426B (zh) | 包含含有il-2蛋白及cd80蛋白之融合蛋白與自然殺手細胞的用於治療癌症的藥學組成物 | |
| AU2012281131B2 (en) | Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment | |
| Madany et al. | Immunobiology and immunotherapeutic targeting of glioma stem cells | |
| EP4004219A1 (en) | T cell receptors and methods of use thereof | |
| Smith et al. | Immunotherapy of colorectal cancer | |
| JP2023526416A5 (https=) | ||
| Subklewe | Current status of immunotherapy in acute myeloid leukemia | |
| US20180028630A1 (en) | Compositions and methods for therapeutic anti-cancer vaccination | |
| Witt | Cripto-1: potential target for cancer immunotherapy?! |